Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Postmenopausal women with breast cancer (BC) are at increased risk for bone loss. Bisphosphonates improve bone mineral density (BMD) in normal postmenopausal women. The purpose of this study was to determine if immediate treatment with zoledronic acid preserves BMD in postmenopausal women with BC st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hines, Stephanie L., Mincey, Betty, Dentchev, Todor, Sloan, Jeff A., Perez, Edith A., Johnson, David B., Schaefer, Paul L., Alberts, Steve, Liu, Heshan, Kahanic, Stephen, Mazurczak, Miroslaw A., Nikcevich, Daniel A., Loprinzi, Charles L.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3907065/
https://ncbi.nlm.nih.gov/pubmed/19214743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-009-0332-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars